For detailed information on this center's transplant program (including program description, attending physicians, types of patients treated, cell sources used), please contact the center directly.
Center-Specific Analysis
This analysis includes ONLY patients who received their FIRST ALLOGENEIC* transplant
between January 1, 2008 and December 31, 2010 using unrelated or related donors, and
who had at least a 100-day follow-up.
- This center reported survival status data for 7 patients.
- The actual one-year survival of these patients is 57%.
- Based on a national average for patients like those transplanted at this center, 95% of the time the one-year survival is expected to be between 29% and 92% for patients at this center.
- This center's actual results are similar to the expected range for this center.
*Allogeneic means using cells from a person other than the patient.
For help with understanding these statistics, please see Understanding Transplant Outcomes (PDF).
Survival by Patient's Age, Disease Type and Stage
If you do not find your disease in the statistics below, it may be combined with other similar diseases in a category. Please refer to our broad disease categories page for more information.
Further information about this center, including the number and type of
transplants performed in each of the last three years, and the support groups
offered, may be found in the BMT InfoNet Transplant Center Directory:
http://www.bmtinfonet.org/transplantcenters.
BMT InfoNet (Blood & Marrow Transplant Information Network) is a
nonprofit organization that provides information and emotional support
to transplant patients and their families.
Please take a
brief
survey to share your feedback on the transplant center informational listings.